Riskpilot← Back to searchSign inGet full accessKIP MEDISIN AS
ASActiveOrg 921966733Munkerudveien 72, 1165 OsloMedical specialists activities · NACE 8622Est. 20181 employees
Revenue 2024
NOK 1,6M
-2% vs 2023
EBITDA margin
23.8%
-34% vs 2023
Equity ratio
65.0%
Financial strength
Net profit 2024
NOK 437K
+48% vs 2023
| Revenue | NOK 1,6M | -2% |
| EBITDA | NOK 376K | -34% |
| Net profit | NOK 437K | +48% |
| Total assets | NOK 2M | +23% |
| Equity | NOK 1,3M | +3% |
| Employees | 1 | — |
Legal name
KIP MEDISIN AS
Org number
921966733
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
20. desember 2018
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Kjell ingar pettersen
Company purpose
Legetjenester, medisinske tjenester, helsetjenester. I tillegg driver selskapet med handel med aksjer verdipapirer, herunder lånefinansierte investeringer med verdipapirer og valuta, hvor selskapet kan pantsette sine aktiva i denne forbindelse.
Address
Munkerudveien 72, 1165 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 238 | 1 898 | 1 552 | 1 618 | 1 579 |
| Staff expenses | −842 | −787 | −991 | −899 | −937 |
| EBITDA | 134 | 775 | 202 | 569 | 376 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 134 | 775 | 202 | 569 | 376 |
| Net financials | −0 | −0 | −0 | −146 | 152 |
| Profit before tax | 134 | 775 | 202 | 423 | 528 |
| Tax | 32 | 173 | 47 | 128 | 91 |
| Net profit | 102 | 602 | 155 | 295 | 437 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 801 | 1 320 | 1 353 | 1 623 | 1 990 |
| Equity | 205 | 807 | 963 | 1 257 | 1 294 |
| Long-term debt | 200 | 100 | 0 | 0 | 0 |
| Short-term debt | 396 | 413 | 390 | 366 | 696 |
| Total debt | 596 | 513 | 390 | 366 | 696 |
EBITDA margin
23.8%
This company
15.8%
Market median
+51% vs market
20202024
Equity ratio
65.0%
This company
38.2%
Market median
+70% vs market
20202024
Return on equity
33.7%
This company
18.4%
Market median
+83% vs market
20202024
Net profit margin
27.7%
This company
8.1%
Market median
+242% vs market
20202024
Asset turnover
0.79×
This company
1.12×
Market median
-29% vs market
20202024
Debt / equity
0.54×
This company
0.62×
Market median
+13% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2018 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
KIP MEDISIN AS 
KARDIO PREVENT ASBoard members of KIP MEDISIN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kjell Ingar Pettersen | Chairman | 0 companies |